Journal of Hematology & Oncology is the official journal of the Chinese American Hematologist and Oncologist Network.
Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia
Despite the impressive complete remission (CR) induced by CD19 CAR-T cell therapy in B-ALL, the high rate of complete responses is sometimes limited by the emergence of CD19-negative leukemia. Bispecific CAR-m...
Citation: Journal of Hematology & Oncology 2020 13:30